Division of Cardiovascular Medicine Archive — Page 9 of 12
-
September 20, 2018
New HIV research training program launched
With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs. -
September 6, 2018
‘Borderline’ lung hypertension should not be ignored: studies
Pulmonary hypertension is a common complication of chronic diseases that occurs when there is increased blood pressure in the arteries carrying blood from the right side of the heart to the lungs. -
September 5, 2018
Unleashing TIGER on small RNAs
Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs. -
August 27, 2018
VUMC mourns noted cardiologist Crenshaw
Marshall H. Crenshaw, MD, assistant professor of Medicine in the Division of Cardiology, died Aug. 23. He was 62. -
July 12, 2018
Transplant Center leads way in using hearts from hepatitis C donors
Medical teams at the Vanderbilt Transplant Center (VTC) are leading the way in utilization of hepatitis C-exposed donors for heart transplantation. -
June 7, 2018
Enzyme protects against obesity-related heart disease
Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction. -
May 29, 2018
New research finds lung cancer risk drops substantially within five years of quitting smoking
Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer. That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.